Toronto Gestational Glucose Tolerance Cohort
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-60
SponsorMount Sinai Hospital, Canada
About this trial
In this prospective observational cohort study, women representing the full spectrum of gestational glucose tolerance status are undergoing longitudinal cardiometabolic characterization at regular intervals in the years after the index pregnancy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Pregnant women
Disqualifiers
Pre-existing diabetes before the index pregnancy
Trial population
The study population consists of pregnant women across the full spectrum of gestational glucose tolerance
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
There is no intervention. An exposure of interest is glucose tolerance status in pregnancy
Other intervention
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Glucose tolerance status
Glucose tolerance is assessed on oral glucose tolerance test
Time frame
10 years after pregnancySponsors and contacts
Click on the lead sponsor to view all of their trials.
Mount Sinai Hospital, Canada
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Source ClinicalTrials.gov